Foley Equipped
Insights

Foley Advises EpiVax in Acquisition by SV Health Investors

Foley & Lardner LLP served as legal advisor to EpiVax Inc., a leading bioanalytical contract research organization specializing in immunogenicity risk assessments for pharmaceutical and biotech companies, in its acquisition by SV Health Investors, a health care and life sciences focused private investment firm.

EpiVax is a pioneer in pre-clinical drug development, serving as a trusted scientific advisor to life sciences clients. Headquartered in Providence, Rhode Island, EpiVax’s predictive analytical software platform and in vitro laboratory services enable life sciences companies to identify safety and efficacy risks early in drug development, reducing timelines and R&D costs. In partnership with SVHI, EpiVax will continue expanding its capabilities and services, including the planned launch of advanced computational tools, cell-based assay applications, and broader analytical consulting services.

Foley’s health care transactions team was led by partner Joe Derrigo with support from senior counsel Sarah Field and associate Miguel Beltran, partner Jordan Bergmann (Tax), partner Nathan Beaver (Regulatory), and senior counsel Kelsey O’Gorman (Executive Compensation & Benefits).

Disclaimer

AUTHOR(S):

POSTED:

Subscribe to our newsletter
Subscribe

© 2025 Foley & Lardner LLP
Attorney Advertisement
Images of people may not be Foley personnel.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome.